Showing 1 - 7 results of 7 for search 'Emma R Job', query time: 0.04s Refine Results
  1. 1
    Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection

    Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection by Michelle D. Tate, Emma R. Job, Yi-Mo Deng, Vithiagaran Gunalan, Sebastian Maurer-Stroh, Patrick C. Reading

    Published 2014-03-01
    Get full text
    Article
  2. 2
    Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells.

    Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells. by Anouk Smet, Joao Paulo Portela Catani, Tine Ysenbaert, Amanda Gonçalves, Harry Kleanthous, Thorsten U Vogel, Xavier Saelens, Emma R Job

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

    Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. by Emma R Job, Barbara Bottazzi, Brad Gilbertson, Kathryn M Edenborough, Lorena E Brown, Alberto Mantovani, Andrew G Brooks, Patrick C Reading

    Published 2013-01-01
    Get full text
    Article
  4. 4
    A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.

    A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody. by Sarah De Baets, Judith Verhelst, Silvie Van den Hoecke, Anouk Smet, Michael Schotsaert, Emma R Job, Kenny Roose, Bert Schepens, Walter Fiers, Xavier Saelens

    Published 2015-01-01
    Get full text
    Article
  5. 5
    <italic toggle="yes">In Vivo</italic> Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression

    <italic toggle="yes">In Vivo</italic> Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression by Silvie Van den Hoecke, Marlies Ballegeer, Bram Vrancken, Lei Deng, Emma R. Job, Kenny Roose, Bert Schepens, Lien Van Hoecke, Philippe Lemey, Xavier Saelens

    Published 2021-08-01
    Get full text
    Article
  6. 6
    Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase

    Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase by João Paulo Portela Catani, Emma R. Job, Tine Ysenbaert, Anouk Smet, Satyajit Ray, Lauren LaRue, Svetlana Stegalkina, Mario Barro, Thorsten U. Vogel, Xavier Saelens

    Published 2022-01-01
    Get full text
    Article
  7. 7
    Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection.

    Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection. by Sarah L Londrigan, Michelle D Tate, Emma R Job, Jessica M Moffat, Linda M Wakim, Christopher A Gonelli, Damien F J Purcell, Andrew G Brooks, Jose A Villadangos, Patrick C Reading, Justine D Mintern

    Published 2015-01-01
    Get full text
    Article

Search Tools: